Hiba F Muddather

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Acute Coronary Syndrome

Top Venues

Current issues in molecular biology

Therapeutics and clinical risk management

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Nikoletta Szemerédi, Zsuzsanna Schelz, Dária Antónia Horvath, Bálint Rácz, András G Szatmári, Hiba F Muddather, Noémi Bózsity, István Zupkó, Gabriella Spengler
Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines. Pharmaceutics 16 (7) (2024)
Zsuzsanna Schelz, Hiba F Muddather, Fatemeh Sheihaki Jaski, Noémi Bózsity, István Zupkó
An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer. Current issues in molecular biology 46 (7) (2024)
Zsuzsanna Schelz, Hiba F Muddather, Fatemeh Sheihaki Jaski, Noémi Bózsity, István Zupkó
An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer. Current issues in molecular biology 46 (7) (2024)
Nikoletta Szemerédi, Zsuzsanna Schelz, Dária Antónia Horvath, Bálint Rácz, András G Szatmári, Hiba F Muddather, Noémi Bózsity, István Zupkó, Gabriella Spengler
Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines. Pharmaceutics 16 (7) (2024)
Nikoletta Szemerédi, Zsuzsanna Schelz, Dária Antónia Horvath, Bálint Rácz, András G Szatmári, Hiba F Muddather, Noémi Bózsity, István Zupkó, Gabriella Spengler
Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines. Pharmaceutics 16 (7) (2024)
Zsuzsanna Schelz, Hiba F Muddather, István Zupkó
Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance. Antibiotics (Basel, Switzerland) 12 (9) (2023)
Kannan O Ahmed, Ashraf M Ahmed, Mojahed B Wali, Ali H Ali, Mustafa M Azhari, Anas Babiker, Bashir A Yousef, Hiba F Muddather
Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan. Therapeutics and clinical risk management 18 (2022)
Hiba F Muddather, Moawia Mohammed Ali Elhassan, Areeg Faggad
Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study. JCO global oncology 7 (2021)